Background—Myocardial ischemia provides a potent stimulus to angiogenesis, and the
mobilization and differentiation of endothelial progenitor cells (EPCs) has been shown to be …

C-reactive protein (CRP), a predictor of future cardiovascular diseases, has been reported to
damage the vascular wall by inducing endothelial dysfunction and inflammation. This …

Objective—C-reactive protein (CRP) has been suggested to participate in the development
of atherosclerosis, in part, by promoting endothelial dysfunction and impairing endothelial …

Background Endothelial progenitor cells (EPC) are present in peripheral blood and can
develop a functional endothelial phenotype. The number and function of circulating EPCs …

Endothelial progenitor cells (EPCs) move towards injured endothelium or inflamed tissues
and incorporate into foci of neovascularisation, thereby improving blood flow and tissue …

Background—The maintenance of endothelial integrity plays a critical role in preventing
atherosclerotic disease progression. Endothelial progenitor cells (EPCs) were …

Background—Transplantation of endothelial progenitor cells (EPCs) improves
neovascularization after ischemia, but patients with coronary artery disease (CAD) or …

Cell therapy with endothelial progenitor cells (EPCs) is an emerging therapeutic option to
promote angiogenesis or endothelial repair. Although the release of angiogenic paracrine …

Endothelial progenitor cells (EPCs) are mobilized from the bone marrow into the peripheral
circulation, home to sites of injury, and incorporate into foci of neovascularization, thereby …

Background and Purpose—Disruption of the endothelial layer is the first step in the
atherogenic process. Experimental studies have shown that endothelial progenitor cells …